LEADER 01203nam  2200349z- 450 
001 9910689422903321
005 20161209101113.0
035   $a(CKB)5600000000079884
035   $a(BIP)021844418
035   $a(EXLCZ)995600000000079884
100   $a20211123c2001uuuu  -u-         -
101 0 $aeng
200 10$aFACA $econflicts of interest and vaccine development--preserving the integrity of the process : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, June 15, 2000
215   $a1 online resource (iii, 193 p.) $cill
311   $a0-16-066248-6 
517   $aFACA 
606   $aExecutive advisory bodies$xCorrupt practices$zUnited States
606   $aConflict of interests$zUnited States
606   $aVaccines$zUnited States
610   $aExecutive advisory bodies
610   $aConflict of interests
610   $aVaccines
610   $aBusiness & economics
610   $aLaw
610   $aMedical
615  0$aExecutive advisory bodies$xCorrupt practices
615  0$aConflict of interests
615  0$aVaccines
906   $aBOOK
912   $a9910689422903321
996   $aFACA$93138464
997   $aUNINA